本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amphastar Pharmaceuticals

23.30
-0.5800-2.43%
盘后23.650.3500+1.50%16:55 EDT
成交量:57.80万
成交额:1,355.44万
市值:10.98亿
市盈率:8.43
高:23.97
开:23.88
低:23.27
收:23.88
数据加载中...
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]